See more : Jiande International Holdings Limited (0865.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Concord Acquisition Corp III (CNDB-UN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Concord Acquisition Corp III, a leading company in the Shell Companies industry within the Financial Services sector.
- JCR Pharmaceuticals Co., Ltd. (4552.T) Income Statement Analysis – Financial Results
- WONIK Materials Co.,Ltd. (104830.KQ) Income Statement Analysis – Financial Results
- Torrent Pharmaceuticals Limited (TORNTPHARM.NS) Income Statement Analysis – Financial Results
- Prime Focus Limited (PFOCUS.BO) Income Statement Analysis – Financial Results
- ResMed Inc. (RMD.AX) Income Statement Analysis – Financial Results
Concord Acquisition Corp III (CNDB-UN)
About Concord Acquisition Corp III
Concord Acquisition Corp III does not have significant operations. It intends to effect a merger, stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 4.87M | 1.17M | 0.00 |
| Gross Profit | -4.87M | -1.17M | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 1.17M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 4.87M | 1.17M | 361.57K |
| Other Expenses | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.87M | 1.17M | 361.57K |
| Cost & Expenses | 4.87M | 1.17M | 361.57K |
| Interest Income | 6.80M | 5.09M | 21.69K |
| Interest Expense | 0.00 | 5.09M | 0.00 |
| Depreciation & Amortization | 167.90K | -21.33M | 236.56K |
| EBITDA | -4.87M | -22.51M | -361.57K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% |
| Operating Income | -4.87M | -1.17M | -361.57K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 4.26M | 26.42M | 9.53M |
| Income Before Tax | -610.01K | 25.25M | 9.17M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 1.39M | 995.21K | -433.88 |
| Net Income | -2.00M | 24.26M | 9.17M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% |
| EPS | -0.09 | 0.56 | 0.21 |
| EPS Diluted | -0.09 | 0.56 | 0.21 |
| Weighted Avg Shares Out | 23.00M | 43.13M | 43.13M |
| Weighted Avg Shares Out (Dil) | 23.00M | 43.13M | 43.13M |
Source: https://incomestatements.info
Category: Stock Reports